A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma

por Okusaka, Takuji, Morimoto, Manabu, Eguchi, Yuichiro, Nakamura, Shinichiro, Iino, Shuichi, Kageyama, Rie
Publicado 2023

A phase 1b study of transforming growth factor-beta receptor I inhibitor galunisertib in combination with sorafenib in Japanese patients with unresectable hepatocellular carcinoma

por Ikeda, Masafumi, Morimoto, Manabu, Tajimi, Masaomi, Inoue, Koichi, Benhadji, Karim A., Lahn, Michael M. F., Sakai, Daisuke
Publicado 2018

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma

por Fukushima, Taito, Morimoto, Manabu, Kobayashi, Satoshi, Ueno, Makoto, Sano, Yusuke, Kawano, Kuniyuki, Asama, Hiroyuki, Nagashima, Shuhei, Maeda, Shin
Publicado 2021

Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignan...

por Kobayashi, Satoshi, Ueno, Makoto, Nagashima, Shuhei, Sano, Yusuke, Kawano, Kuniyuki, Fukushima, Taito, Asama, Hiroyuki, Tezuka, Shun, Morimoto, Manabu
Publicado 2021

Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

por Okusaka, Takuji, Aramaki, Takeshi, Inaba, Yoshitaka, Nakamura, Shinichiro, Morimoto, Manabu, Moriguchi, Michihisa, Sato, Takashi, Ikawa, Yuta, Ikeda, Masafumi, Furuse, Junji
Publicado 2015

A case of pancreatic mucinous cystadenocarcinoma with malignant ascites without recurrence for more than 8 years after surgery

por Tezuka, Shun, Ueno, Makoto, Kobayashi, Satoshi, Fukushima, Taito, Nasu, Ryuji, Washimi, Kota, Yamamoto, Naoto, Morinaga, Soichiro, Morimoto, Manabu, Maeda, Shin
Publicado 2022

FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study

por Kobayashi, Satoshi, Tezuka, Shun, Yamachika, Yui, Tsunoda, Shotaro, Nagashima, Shuhei, Tozuka, Yuichiro, Fukushima, Taito, Morimoto, Manabu, Ueno, Makoto, Furuse, Junji, Maeda, Shin
Publicado 2023

Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced...

por Takada, Juichi, Hidaka, Hisashi, Nakazawa, Takahide, Kondo, Masaaki, Numata, Kazushi, Tanaka, Katsuaki, Matsunaga, Kotaro, Okuse, Chiaki, Kobayashi, Satoshi, Morimoto, Manabu, Ohkawa, Shinichi, Koizumi, Wasaburo
Publicado 2015

Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational study

por Nozaki, Akito, Chuma, Makoto, Hara, Koji, Moriya, Satoshi, Fukuda, Hiroyuki, Numata, Kazushi, Tanaka, Katsuaki, Morimoto, Manabu, Sakamaki, Kentaro, Yamanaka, Takeharu, Kondo, Masaaki, Maeda, Shin
Publicado 2021

The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection

por Murakawa, Masaaki, Aoyama, Toru, Miyagi, Yohei, Kobayashi, Satoshi, Ueno, Makoto, Morimoto, Manabu, Numata, Masakatsu, Yamamoto, Naoto, Tamagawa, Hiroshi, Yukawa, Norio, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Publicado 2019

First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors

por Doi, Toshihiko, Yoh, Kiyotaka, Shitara, Kohei, Takahashi, Hideaki, Ueno, Makoto, Kobayashi, Satoshi, Morimoto, Manabu, Okusaka, Takuji, Ueno, Hideki, Morizane, Chigusa, Okano, Naohiro, Nagashima, Fumio, Furuse, Junji
Publicado 2018

Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second‐line treatment regimen for unresectable pancreatic cancer: A real‐world analysis

por Tezuka, Shun, Ueno, Makoto, Oishi, Ritsuko, Nagashima, Shuhei, Sano, Yusuke, Kawano, Kuniyuki, Tanaka, Satoshi, Fukushima, Taito, Asama, Hiroyuki, Konno, Naoki, Kobayashi, Satoshi, Morimoto, Manabu, Maeda, Shin
Publicado 2021

Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection

por Murakawa, Masaaki, Kawahara, Shinnosuke, Takahashi, Daishi, Kamioka, Yuto, Yamamoto, Naoto, Kobayashi, Satoshi, Ueno, Makoto, Morimoto, Manabu, Sawazaki, Sho, Tamagawa, Hiroshi, Ohshima, Takashi, Yukawa, Norio, Rino, Yasushi, Morinaga, Soichiro
Publicado 2023

Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

por Aoyama, Toru, Miyagi, Yohei, Murakawa, Masaaki, Yamaoku, Koichiro, Atsumi, Yosuke, Shiozawa, Manabu, Ueno, Makoto, Morimoto, Manabu, Oshima, Takashi, Yukawa, Norio, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Publicado 2017

Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer

por Kobayashi, Satoshi, Koizume, Shiro, Takahashi, Tomoko, Ueno, Makoto, Oishi, Ritsuko, Nagashima, Shuhei, Sano, Yusuke, Fukushima, Taito, Tezuka, Shun, Morimoto, Manabu, Nakamura, Sho, Narimatsu, Hiroto, Ruf, Wolfram, Miyagi, Yohei
Publicado 2021

Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel: A ret...

por Tozuka, Yuichiro, Ueno, Makoto, Kobayashi, Satoshi, Morimoto, Manabu, Fukushima, Taito, Sano, Yusuke, Kawano, Kuniyuki, Hanaoka, Akane, Tezuka, Shun, Asama, Hiroyuki, Moriya, Satoshi, Morinaga, Soichiro, Ohkawa, Shinichi, Maeda, Shin
Publicado 2022

High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomas

por Fukuda, Hiroyuki, Numata, Kazushi, Nozaki, Akito, Kondo, Masaaki, Morimoto, Manabu, Maeda, Shin, Tanaka, Katsuaki, Ohto, Masao, Ito, Ryu, Ishibashi, Yoshiharu, Oshima, Noriyoshi, Ito, Ayao, Zhu, Hui, Wang, Zhi-Biao
Publicado 2013

Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy

por Aoyama, Toru, Kazama, Keisuke, Miyagi, Yohei, Murakawa, Masaaki, Yamaoku, Koichiro, Atsumi, Yosuke, Shiozawa, Manabu, Ueno, Makoto, Morimoto, Manabu, Oshima, Takashi, Yukawa, Norio, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Publicado 2017

Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

por Ikeda, Masafumi, Kudo, Masatoshi, Aikata, Hiroshi, Nagamatsu, Hiroaki, Ishii, Hiroshi, Yokosuka, Osamu, Torimura, Takuji, Morimoto, Manabu, Ikeda, Kenji, Kumada, Hiromitsu, Sato, Tosiya, Kawai, Ikuko, Yamashita, Toru, Horio, Hiroshi, Okusaka, Takuji
Publicado 2017

Treatment of hepatocellular carcinoma with hepatic vein tumor thrombosis protruding into the inferior vena cava by conversion surgery following chemotherapy with regorafenib: a cas...

por Takeda, Kazuhisa, Tsurumaru, Yuji, Yamamoto, Yuji, Araki, Kentaro, Kogure, Yu, Mori, Koichi, Nakagawa, Kazuya, Shimizu, Tetsuya, Matsuda, Goro, Niino, Hitoshi, Sekido, Hitoshi, Kobayashi, Satoshi, Morimoto, Manabu, Kunisaki, Chikara, Endo, Itaru
Publicado 2020